Developer docs
API playgroundTry for free, no card

Search company profiles

EvexiPEL

Full company profile

uuid002uv8t

Namestring
EvexiPEL
Legal namestring
EVEXIAS Health Solutions
Websiteurl
pellet.life
Company typeenum
Private
Founded yearint
2018
Descriptiontext

EvexiPEL is a hormone replacement therapy (HRT) brand and clinical method operated by EVEXIAS Health Solutions, a Texas-based private healthcare company founded by Dr. Terri DeNeui. The company delivers bioidentical estradiol and testosterone pellet therapy through a network of EvexiPEL Certified Providers across the United States, supplemented by two company-operated EVEXIAS Medical Centers in Southlake, TX and Rockwall, TX. Its core technology combines a patented hormone pellet formulation — produced in an FDA 503B registered outsourcing facility and including trace amounts of an anti-inflammatory — with a proprietary insertion technique also developed by Dr. DeNeui, designed to deliver steady hormone dosing over 3–5 months (women) or 4–6 months (men) via a 15–30 minute in-office procedure.

The business operates a two-sided go-to-market: a direct-to-consumer motion using content marketing, social media, and a provider finder tool to direct prospective patients to certified practitioners, paired with an enterprise field sales motion that recruits and certifies healthcare providers into the network. Revenue is generated indirectly through pellet shipments and procedure fees at certified clinics, plus direct service revenue at the Texas flagship centers, with most lab testing and consultations covered by insurance and pellet therapy coverage varying by insurer. Personalized treatment plans may include progesterone, thyroid hormones, nutraceuticals, and lifestyle recommendations.

No external institutional funding, public listing, or headcount figures are disclosed. The company holds no identified patents or trademarks in the source data beyond the referenced patented pellet formulation, and there are no recorded M&A, regulatory actions, or leadership changes on file. Strategic emphasis is on expanding the certified provider base and DTC patient acquisition, as evidenced by a Q4 2023 multi-city billboard campaign in Dallas, Fort Lauderdale, and Phoenix.

Short descriptiontext

EvexiPEL is a Texas-based hormone replacement therapy brand under EVEXIAS Health Solutions that delivers patented bioidentical hormone pellet therapy through a national network of certified practitioners and two flagship clinics, serving adults with hormone imbalance, menopause, and andropause symptoms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSouthlake, United States
HQ citystring
Southlake
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hormone replacement therapy, bioidentical hormone pellets, menopause and andropause treatment, pellet insertion procedure, certified provider training
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Hormone Replacement Therapy
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hormone Therapy Services
TypeSubscription Recurring
Description

EvexiPEL generates revenue through hormone pellet therapy services delivered by certified practitioners. Services include consultation, hormone testing, pellet insertion procedures, and ongoing monitoring throughout treatment cycles of 3-5 months.

pellet.life
2Laboratory Testing
TypeProfessional Services
Description

Hormone lab testing services for evaluating hormone levels and determining candidacy for therapy. Most labs and consultations are covered by insurance.

pellet.life
3Nutraceuticals and Lifestyle Products
TypeSubscription Recurring
Description

Treatment plans may include nutraceuticals and lifestyle recommendations as part of comprehensive hormone optimization programs.

pellet.life
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1EvexiPEL Method
Description

Proprietary hormone replacement therapy (HRT) method featuring patented hormone pellets and a proprietary insertion technique, offered exclusively through EVEXIAS Health Solutions.

pellet.life
Core offering1 text field

EvexiPEL provides a proprietary hormone replacement therapy (HRT) method centered on patented bioidentical estradiol and testosterone pellets formulated with trace amounts of an anti-inflammatory and produced in an FDA 503B registered outsourcing facility. The pellets are inserted via a proprietary technique developed by Dr. Terri DeNeui, delivering steady-state hormone levels for 3-5 months in women and 4-6 months in men. Treatment is delivered through a national network of EvexiPEL Certified Providers and two company-operated EVEXIAS Medical Centers in Texas, with supporting offerings including personalized treatment plans, hormone lab testing, and a practitioner certification program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Steady hormone delivery for 3-5 months in women, 4-6 months in men
+3 more records
Product overview1 text field

EvexiPEL is a hormone therapy company offering a unified method combining patented hormone pellets with a proprietary insertion technique. The core product is the EvexiPEL Method for estradiol and testosterone pellet therapy, delivered through an in-office insertion procedure (15-30 minutes) that provides 3-5 months of steady hormone dosing. Treatment is administered exclusively through EvexiPEL Certified Providers who create personalized treatment plans that may also include progesterone, thyroid hormones, and nutraceuticals. The company operates under EVEXIAS Health Solutions and maintains an FDA 503B outsourcing facility for pellet production.

Product and service4 records
1EvexiPEL Method
CategoryHormone Replacement Therapy
Description

A proprietary hormone pellet therapy method for estradiol and testosterone replacement, combining patented hormone pellets developed in an FDA 503B outsourcing facility with a proprietary insertion technique designed to reduce bruising, minimize scar tissue, and provide steady hormone dosing over 3-5 month treatment cycles. Delivered exclusively through EvexiPEL Certified Providers to adult men and women with hormone imbalance.

2Hormone Pellet Insertion Procedure
CategoryHormone Replacement Therapy
Description

A 15-30 minute in-office procedure involving a small incision to insert hormone pellets beneath the skin, designed to be minimally invasive with reduced pain and bruising compared to traditional pellet therapy. Performed by EvexiPEL Certified Providers for individual patients.

3Personalized Hormone Optimization Treatment Plans
CategoryHormone Optimization Services
Description

Customized hormone optimization programs that may include estradiol and testosterone pellet therapy, progesterone, thyroid hormones, nutraceuticals, and lifestyle recommendations tailored to individual patient lab results, medical history, and symptoms. Offered to patients by EvexiPEL Certified Providers.

4EvexiPEL Certified Provider Network
CategoryHealthcare Provider Certification Network
Description

A nationwide network of healthcare practitioners trained and certified in the EvexiPEL Method, offering hormone therapy services through private medical practices with advanced medical education and training from industry-leading practitioners and researchers. Accessed by individual patients via the provider finder tool.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1EvexiPEL Certified Practitioners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Network of healthcare practitioners certified in the EvexiPEL Method who deliver hormone pellet therapy services. Certified providers receive advanced medical education, training, and access to proprietary therapies and technologies. Practitioners can enhance patient care and grow their practices through the program.

pellet.life
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Manufacturing partner producing EvexiPEL patented hormone pellets in an FDA 503B registered outsourcing facility. The facility ensures purity, potency, and precise dosing of pellets with trace amounts of anti-inflammatory formulation.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

EVEXIAS Health Solutions is EvexiPEL's parent company and offers a broader portfolio of wellness, nutraceutical, and training products beyond the EvexiPEL Method. It is the same operating entity viewed at the parent level rather than as the flagship pellet brand.

TypeDirect peer
Description

BioTE is the largest U.S. hormone pellet therapy network, distributing bioidentical hormone pellets through a national certified-provider program. Its business model — proprietary pellet, certification curriculum, recurring insertion cycles — is the closest direct analogue to EvexiPEL.

TypeDirect peer
Description

Pellecome provides a hormone pellet product and trains practitioners in pellet insertion, operating a certification-based distribution model that parallels EvexiPEL's certified-provider network and recurring pellet supply economics.

TypeDirect peer
Description

Defy Medical is a clinic and telehealth provider of hormone replacement therapy, including pellet-based protocols, serving men and women with age-related hormone decline. It overlaps with EvexiPEL's patient base and treatment offerings.

TypeEmerging player
Description

Marek Health is a men's hormone optimization and TRT provider operating via telehealth and partner clinics. It is an emerging competitor pursuing the same male hormone replacement demand with a more digital-first delivery model.

TypeDirect peer
Description

Ageless Men's Health operates a national chain of clinics focused on testosterone replacement and men's hormone optimization. It is a direct competitor for EvexiPEL's male patient cohort and uses a similar clinic-network growth model.

TypeEmerging player
Description

Winona is a telehealth platform providing bioidentical hormone replacement therapy, primarily to women in perimenopause and menopause. It competes for the same women's hormone optimization demand as EvexiPEL but via a remote prescribing model rather than in-office pellets.

TypeDirect peer
Description

SottoPelle markets its own proprietary subcutaneous hormone pellet therapy and trains physicians in its proprietary insertion technique, mirroring EvexiPEL's combination of patented pellet plus proprietary insertion method delivered through certified providers.

TypeDirect peer
Description

BodyLogicMD is a national network of physicians specializing in bioidentical hormone replacement therapy and preventive wellness for men and women. It competes directly with EvexiPEL for the same mid-life hormone optimization patient segment and practitioner relationships.

TypeBroad incumbent
Description

Large pharmaceutical companies market FDA-approved HRT products (patches, gels, injectables) that compete with EvexiPEL's pellets for the same hormone-replacement prescriptions. They represent the established, mass-market alternative to compounded pellet therapy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EvexiPEL

Hormone Replacement Therapypellet.life

EvexiPEL is a Texas-based hormone replacement therapy brand under EVEXIAS Health Solutions that delivers patented bioidentical hormone pellet therapy through a national network of certified practitioners and two flagship clinics, serving adults with hormone imbalance, menopause, and andropause symptoms.

What EvexiPEL does

EvexiPEL is a hormone replacement therapy (HRT) brand and clinical method operated by EVEXIAS Health Solutions, a Texas-based private healthcare company founded by Dr. Terri DeNeui. The company delivers bioidentical estradiol and testosterone pellet therapy through a network of EvexiPEL Certified Providers across the United States, supplemented by two company-operated EVEXIAS Medical Centers in Southlake, TX and Rockwall, TX. Its core technology combines a patented hormone pellet formulation — produced in an FDA 503B registered outsourcing facility and including trace amounts of an anti-inflammatory — with a proprietary insertion technique also developed by Dr. DeNeui, designed to deliver steady hormone dosing over 3–5 months (women) or 4–6 months (men) via a 15–30 minute in-office procedure.

The business operates a two-sided go-to-market: a direct-to-consumer motion using content marketing, social media, and a provider finder tool to direct prospective patients to certified practitioners, paired with an enterprise field sales motion that recruits and certifies healthcare providers into the network. Revenue is generated indirectly through pellet shipments and procedure fees at certified clinics, plus direct service revenue at the Texas flagship centers, with most lab testing and consultations covered by insurance and pellet therapy coverage varying by insurer. Personalized treatment plans may include progesterone, thyroid hormones, nutraceuticals, and lifestyle recommendations.

No external institutional funding, public listing, or headcount figures are disclosed. The company holds no identified patents or trademarks in the source data beyond the referenced patented pellet formulation, and there are no recorded M&A, regulatory actions, or leadership changes on file. Strategic emphasis is on expanding the certified provider base and DTC patient acquisition, as evidenced by a Q4 2023 multi-city billboard campaign in Dallas, Fort Lauderdale, and Phoenix.

EvexiPEL firmographics

Firmographics
Name
EvexiPEL
Legal name
EVEXIAS Health Solutions
Website
https://pellet.life
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
EvexiPEL is a Texas-based hormone replacement therapy brand under EVEXIAS Health Solutions that delivers patented bioidentical hormone pellet therapy through a national network of certified practitioners and two flagship clinics, serving adults with hormone imbalance, menopause, and andropause symptoms.
Ownership category
akta.pro rank

Where EvexiPEL is headquartered

Location

Headquarters

HQ city
Southlake
HQ country
United States
HQ region
North America

Offices2 records

Markets served

EvexiPEL business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D

Revenue model

  1. Hormone Therapy Services: EvexiPEL generates revenue through hormone pellet therapy services delivered by certified practitioners. Services include consultation, hormone testing, pellet insertion procedures, and ongoing monitoring throughout treatment cycles of 3-5 months.
  2. Laboratory Testing: Hormone lab testing services for evaluating hormone levels and determining candidacy for therapy. Most labs and consultations are covered by insurance.
  3. Nutraceuticals and Lifestyle Products: Treatment plans may include nutraceuticals and lifestyle recommendations as part of comprehensive hormone optimization programs.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

EvexiPEL product offering

Product offering

Core offering

EvexiPEL provides a proprietary hormone replacement therapy (HRT) method centered on patented bioidentical estradiol and testosterone pellets formulated with trace amounts of an anti-inflammatory and produced in an FDA 503B registered outsourcing facility. The pellets are inserted via a proprietary technique developed by Dr. Terri DeNeui, delivering steady-state hormone levels for 3-5 months in women and 4-6 months in men. Treatment is delivered through a national network of EvexiPEL Certified Providers and two company-operated EVEXIAS Medical Centers in Texas, with supporting offerings including personalized treatment plans, hormone lab testing, and a practitioner certification program.

Product overview

EvexiPEL is a hormone therapy company offering a unified method combining patented hormone pellets with a proprietary insertion technique. The core product is the EvexiPEL Method for estradiol and testosterone pellet therapy, delivered through an in-office insertion procedure (15-30 minutes) that provides 3-5 months of steady hormone dosing. Treatment is administered exclusively through EvexiPEL Certified Providers who create personalized treatment plans that may also include progesterone, thyroid hormones, and nutraceuticals. The company operates under EVEXIAS Health Solutions and maintains an FDA 503B outsourcing facility for pellet production.

Differentiator

Problem solved

Functional benefit

Brands

  • EvexiPEL Method: Proprietary hormone replacement therapy (HRT) method featuring patented hormone pellets and a proprietary insertion technique, offered exclusively through EVEXIAS Health Solutions.

Products and services

  • EvexiPEL Method A proprietary hormone pellet therapy method for estradiol and testosterone replacement, combining patented hormone pellets developed in an FDA 503B outsourcing facility with a proprietary insertion technique designed to reduce bruising, minimize scar tissue, and provide steady hormone dosing over 3-5 month treatment cycles. Delivered exclusively through EvexiPEL Certified Providers to adult men and women with hormone imbalance.
  • Hormone Pellet Insertion Procedure A 15-30 minute in-office procedure involving a small incision to insert hormone pellets beneath the skin, designed to be minimally invasive with reduced pain and bruising compared to traditional pellet therapy. Performed by EvexiPEL Certified Providers for individual patients.
  • Personalized Hormone Optimization Treatment Plans Customized hormone optimization programs that may include estradiol and testosterone pellet therapy, progesterone, thyroid hormones, nutraceuticals, and lifestyle recommendations tailored to individual patient lab results, medical history, and symptoms. Offered to patients by EvexiPEL Certified Providers.
  • EvexiPEL Certified Provider Network A nationwide network of healthcare practitioners trained and certified in the EvexiPEL Method, offering hormone therapy services through private medical practices with advanced medical education and training from industry-leading practitioners and researchers. Accessed by individual patients via the provider finder tool.

Quantifiable outcome

  • Steady hormone delivery for 3-5 months in women, 4-6 months in men
  • +3 more outcomes

Companies that use EvexiPEL

Customer profile

Named customers8 records

Segments2 records

Ideal customer profiles2 records

EvexiPEL technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

EvexiPEL partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • EvexiPEL Certified PractitionerscoreChannel Partner/ Reseller/ DistributorNetwork of healthcare practitioners certified in the EvexiPEL Method who deliver hormone pellet therapy services. Certified providers receive advanced medical education, training, and access to proprietary therapies and technologies. Practitioners can enhance patient care and grow their practices through the program.
  • FDA 503B Registered Outsourcing FacilitycoreOEM/ Whitelabel/ Licensing PartnerManufacturing partner producing EvexiPEL patented hormone pellets in an FDA 503B registered outsourcing facility. The facility ensures purity, potency, and precise dosing of pellets with trace amounts of anti-inflammatory formulation.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

EvexiPEL competitors and assessment

Company assessment

Broad incumbents

  • EVEXIAS Health Solutions: EVEXIAS Health Solutions is EvexiPEL's parent company and offers a broader portfolio of wellness, nutraceutical, and training products beyond the EvexiPEL Method. It is the same operating entity viewed at the parent level rather than as the flagship pellet brand.
  • Allergan / AbbVie (e.g., AndroGel, estradiol franchises): Large pharmaceutical companies market FDA-approved HRT products (patches, gels, injectables) that compete with EvexiPEL's pellets for the same hormone-replacement prescriptions. They represent the established, mass-market alternative to compounded pellet therapy.

Direct peers

  • BioTE Medical: BioTE is the largest U.S. hormone pellet therapy network, distributing bioidentical hormone pellets through a national certified-provider program. Its business model — proprietary pellet, certification curriculum, recurring insertion cycles — is the closest direct analogue to EvexiPEL.
  • Pellecome: Pellecome provides a hormone pellet product and trains practitioners in pellet insertion, operating a certification-based distribution model that parallels EvexiPEL's certified-provider network and recurring pellet supply economics.
  • Defy Medical: Defy Medical is a clinic and telehealth provider of hormone replacement therapy, including pellet-based protocols, serving men and women with age-related hormone decline. It overlaps with EvexiPEL's patient base and treatment offerings.
  • Ageless Men's Health: Ageless Men's Health operates a national chain of clinics focused on testosterone replacement and men's hormone optimization. It is a direct competitor for EvexiPEL's male patient cohort and uses a similar clinic-network growth model.
  • SottoPelle: SottoPelle markets its own proprietary subcutaneous hormone pellet therapy and trains physicians in its proprietary insertion technique, mirroring EvexiPEL's combination of patented pellet plus proprietary insertion method delivered through certified providers.
  • BodyLogicMD: BodyLogicMD is a national network of physicians specializing in bioidentical hormone replacement therapy and preventive wellness for men and women. It competes directly with EvexiPEL for the same mid-life hormone optimization patient segment and practitioner relationships.

Emerging players

  • Marek Health: Marek Health is a men's hormone optimization and TRT provider operating via telehealth and partner clinics. It is an emerging competitor pursuing the same male hormone replacement demand with a more digital-first delivery model.
  • Winona: Winona is a telehealth platform providing bioidentical hormone replacement therapy, primarily to women in perimenopause and menopause. It competes for the same women's hormone optimization demand as EvexiPEL but via a remote prescribing model rather than in-office pellets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

EvexiPEL social profiles

Digital presence

EvexiPEL compliance and trust

Trust signal

Compliance1 record

EvexiPEL financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EvexiPEL leadership team

Management profile

Number of profiles

Profiles1 record

EvexiPEL funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EvexiPEL M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EvexiPEL

What does EvexiPEL do?

EvexiPEL provides a proprietary hormone replacement therapy (HRT) method centered on patented bioidentical estradiol and testosterone pellets formulated with trace amounts of an anti-inflammatory and produced in an FDA 503B registered outsourcing facility. The pellets are inserted via a proprietary technique developed by Dr. Terri DeNeui, delivering steady-state hormone levels for 3-5 months in women and 4-6 months in men. Treatment is delivered through a national network of EvexiPEL Certified Providers and two company-operated EVEXIAS Medical Centers in Texas, with supporting offerings including personalized treatment plans, hormone lab testing, and a practitioner certification program.

Is EvexiPEL a public or private company?

EvexiPEL is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was EvexiPEL founded?

EvexiPEL was founded in 2018. It employs 11 to 50 people.

Where is EvexiPEL based?

EvexiPEL is headquartered in Southlake, United States, in the North America region.

How does EvexiPEL make money?

Three revenue lines are on record. Hormone Therapy Services are the primary driver. The others are laboratory Testing and nutraceuticals and Lifestyle Products.

Who are EvexiPEL's main competitors?

Broad incumbents on record are EVEXIAS Health Solutions and Allergan / AbbVie (e.g., AndroGel, estradiol franchises). Direct peers are BioTE Medical, Pellecome, Defy Medical, Ageless Men's Health, SottoPelle and BodyLogicMD. Emerging players are Marek Health and Winona.

Does EvexiPEL have an API?

No public API is recorded for EvexiPEL.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales